These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 2532471)

  • 1. Androgen sulfate and glucuronide conjugates in nonhirsute and hirsute women with polycystic ovarian syndrome.
    Matteri RK; Stanczyk FZ; Gentzschein EE; Delgado C; Lobo RA
    Am J Obstet Gynecol; 1989 Dec; 161(6 Pt 1):1704-9. PubMed ID: 2532471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androsterone sulfate: physiology and clinical significance in hirsute women.
    Zwicker H; Rittmaster RS
    J Clin Endocrinol Metab; 1993 Jan; 76(1):112-6. PubMed ID: 8380602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum androsterone conjugates differentiate between acne and hirsutism in hyperandrogenic women.
    Carmina E; Stanczyk FZ; Matteri RK; Lobo RA
    Fertil Steril; 1991 May; 55(5):872-6. PubMed ID: 1827073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous application of an androstenedione gel as an in vivo test of 5 alpha-reductase activity in women.
    Miles RA; Cassidenti DL; Carmina E; Gentzschein E; Stanczyk FZ; Lobo RA
    Fertil Steril; 1992 Oct; 58(4):708-12. PubMed ID: 1426314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ovarian contribution to peripherally derived serum C19 conjugates.
    Matteri RK; Stanczyk FZ; Cassidenti DL; Paulson RJ; Lobo RA
    J Clin Endocrinol Metab; 1992 Sep; 75(3):768-72. PubMed ID: 1387653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
    Stanczyk FZ; Saxena T; Lobo RA
    J Steroid Biochem Mol Biol; 2014 Jan; 139():73-7. PubMed ID: 24121067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome.
    Lobo RA; Goebelsmann U; Horton R
    J Clin Endocrinol Metab; 1983 Aug; 57(2):393-7. PubMed ID: 6223045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of C-19 steroids and 5 alpha-reduced steroid glucuronides in hyperandrogenic and idiopathic hirsute women.
    Brochu M; Bélanger A; Tremblay RR
    Fertil Steril; 1987 Dec; 48(6):948-53. PubMed ID: 2960564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate dependency of C19 conjugates in hirsute hyperandrogenic women and the influence of adrenal androgen.
    Carmina E; Gentzschein E; Stanczyk FZ; Lobo RA
    Hum Reprod; 1995 Feb; 10(2):299-303. PubMed ID: 7769052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased free testosterone but normal 5 alpha-reduced testosterone metabolites in obese premenopausal women.
    Giagulli VA; De Pergola G; Giorgino F; Cignarelli M; Abbaticchio G; Vermeulen A; Giorgino R
    Clin Endocrinol (Oxf); 1992 Jun; 36(6):553-8. PubMed ID: 1424180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of 5 alpha-reductase activity in hirsute women: comparison of serum androstanediol glucuronide with urinary androsterone and aetiocholanolone excretion.
    Gilad S; Chayen R; Tordjman K; Kisch E; Stern N
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):459-64. PubMed ID: 8187312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin modulates peripheral androgen metabolism.
    Serafini P; Lobo RA
    Fertil Steril; 1986 Jan; 45(1):41-6. PubMed ID: 2935426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androsterone glucuronide is a marker of adrenal hyperandrogenism in hirsute women.
    Thompson DL; Horton N; Rittmaster RS
    Clin Endocrinol (Oxf); 1990 Mar; 32(3):283-92. PubMed ID: 2160872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of androstanediol glucuronide, total testosterone, and free testosterone in hirsute women.
    Khoury MY; Baracat EC; Pardini DP; Vieira JG; de Lima GR
    Fertil Steril; 1994 Jul; 62(1):76-80. PubMed ID: 8005308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in androgen conjugate levels in women and men with alopecia.
    Legro RS; Carmina E; Stanczyk FZ; Gentzschein E; Lobo RA
    Fertil Steril; 1994 Oct; 62(4):744-50. PubMed ID: 7926083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated production and metabolic clearance rates of androgens in morbidly obese women.
    Samojlik E; Kirschner MA; Silber D; Schneider G; Ertel NH
    J Clin Endocrinol Metab; 1984 Nov; 59(5):949-54. PubMed ID: 6480813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
    Labrie F; Bélanger A; Cusan L; Candas B
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased 5 alpha-reductase activity in idiopathic hirsutism.
    Serafini P; Lobo RA
    Fertil Steril; 1985 Jan; 43(1):74-8. PubMed ID: 3155511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS; Thompson DL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of endogenous progesterone on serum levels of 5 alpha-reduced androgens in hirsute women.
    Dewis P; Newman M; Anderson DC
    Clin Endocrinol (Oxf); 1984 Oct; 21(4):383-92. PubMed ID: 6542470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.